PLSE250117P17500
- 0.70
- 0.000.00%
Pulse Biosciences Newsroom
Pulse Biosciences Is on Track for IDE Study of PFA Tech This Year
Pulse Biosciences Announces Nanosecond PFA 360° Cardiac Catheter Study Results, 92.4% Success At 3 Months In Initial 30 AF Patients; IDE Study Planned For 2025
Pulse Biosciences Updates Investors on Cardiac Innovations
Pulse Biosciences' Nanosecond PFA Technology to Be Featured in Multiple Presentations at the AF Symposium
Pulse Biosciences Pickes Former Boston Scientific Exec as New CEO
Express News | Pulse Biosciences, Inc. Appoints Paul Laviolette as Chief Executive Officer
Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer
Pulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare Conference
Pulse Biosciences,, On December 18, 2024, The Co's Co-Chairman And Majority Shareholder, Robert W. Duggan, Exercised All Of The Warrants He Acquired In The Co's 2024 Rights Offering, Corresponding To $58.4M Totaling To 5,306,156 Shares Of Company...
Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants
Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery
Insider Buys Additional US$972k In Pulse Biosciences Stock
Insider Purchase: Director at $PLSE (PLSE) Buys 50,000 Shares
Pulse Biosciences CEO Resigns Amid Leadership Transition
Express News | Pulse Biosciences Inc - CEO Burke T. Barrett to Resign Effective December 6, 2024
Sector Update: Health Care Stocks Higher Late Afternoon
Sector Update: Health Care
Pulse Biosciences Stock Rises; Co-Chairman Duggan May Buy Shares
Pulse Biosciences, Inc.'s (NASDAQ:PLSE) Largest Shareholder, Top Key Executive Robert Duggan Sees Holdings Value Fall by 4.8% Following Recent Drop
12 Health Care Stocks Moving In Friday's Intraday Session